in

Profit and Revenue Beat Estimates, Rise 29.6% and 17% Respectively

Income from US formulations business registered 31% growth to Rs 2,409.6 crore, although sequentially it was flat. US formulations business continued its upward trajectory with a formidable YoY growth, driven by volume expansion and new launches over last 12 months. The business accounted for…

Read More

What do you think?

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Why Stock Is Up Despite Declining Metrics

HDFC Life To Raise Up To Rs 1,000 Crore Via Bonds